Science keeps winning! Scientists recently transplanted a pig’s kidney into a human being without immediate rejection by the immune system.
A step in the right direction, the achievement could help ease the shortage of human organs for transplant by using animal organs.
Performed at the NYU Langone Health in New York City, the procedure used the kidney of a pig whose genes had been modified to get rid of a particular molecule which causes human immune systems to reject animal organs.
According to Reuters, the recipient of the pig kidney is a comatose patient who was experiencing kidney dysfunction. The subject’s family consented to the pig kidney transplantation before she was set to be taken off life support.
How was the procedure done?
In the pilot phase of the transplant, the pig kidney was attached to her blood vessels but kept outside the body. This gave researchers access to the kidney for three days in case things were to go awry.
The kidney function after the transplant appears to be normal so far. Turns out the kidney is also making as much urine as expected from a kidney. In fact, Dr. Robert Montgomery, the lead researcher of the study told Reuters that it’s working akin to a human kidney.
The most telling sign of the pig kidney working? The recipient’s kidney function has become normal again. Earlier, the subject’s creatinine levels were abnormal and now they appear stable.
Kidney shortage in India
Researchers across the globe have been working for decades to transplant animal kidneys into humans. Unfortunately, the immediate rejection has remained extremely high among recipients. With this new pig kidney transplant, things may be headed for a shake-up.
According to Narayana Health, almost 200,000 patients in India are awaiting organ donation with only 15,000 available donors. This gap could be filled with animal transplants modelled around this one.
As the chemical industry moves into 2022, strong demand for both commodity and specialty chemicals should keep prices robust throughout the year. The industry could face margin pressures amid raw material cost inflation, which will likely remain high through the first half of 2022.
Blackouts and power cuts in the world’s second-largest economy have drawn attention to fuel supply problems that could complicate the country’s pandemic recovery.
The Federation of Indian Export Organizations (FIEO), an apex body of Indian export promotion organizations, has urged the government to provide freight support to all exports including pharmaceuticals till 31st March 2022, as freight rates have skyrocketed and are likely to somber by March 2022.
In a landmark announcement, the World Health Organization (WHO) has recommended the use of the first-ever malaria vaccine for children. WHO Director-General Tedros Adhanom Ghebreyesus endorsed the RTS,S/AS01 malaria or Mosquirix – a vaccine developed by British drugmaker GlaxoSmithKline (GSK).
China’s power shortages hit growth in the world’s second-biggest economy, threatening more pain for global supply chains, while Europe’s gas squeeze looked set to continue as Russia’s Gazprom showed no sign of hiking exports to the region in October.
The fact that 22 such molecules are going to come out of their patent period will substantially expand the offerings of the Indian companies to people at home and abroad alike and may help fetch extra revenue.
“Current data indicates that neither food nor food packaging is a pathway for the spread of viruses causing respiratory illnesses, including SARS-CoV-2,” according to a new guidance document from the United Nations’ Food and Agriculture Organization (FAO): “In other words, SARS-CoV-2 is not a direct food safety concern.”
The United States has been pushing India to restart vaccine exports as it looks to stem the global spread of the Covid pandemic.
Quess Corp, India’s leading business services provider, announced the launch of its new healthcare vertical to address the shortage of healthcare professionals.